VXRT
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Vaxart expanded its intellectual property portfolio with a European patent protecting its proprietary norovirus vaccine technologyAug 27, 2026
- Vaxart reports additional Phase 1 data supporting potential efficacy of its second-generation norovirus oral pill vaccine candidateSep 11, 2025
- Vaxart's second-gen vaccine shows significantly stronger antibody response than first-gen in clinical dataJun 11, 2025
- Vaxart publishes positive and complete data from a Phase 2b challenge study of its first-generation oral pill norovirus vaccine candidate in Science Translational Medicine.May 14, 2025